| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5536336 | Vaccine | 2017 | 8 Pages |
Abstract
This algorithm is a valid tool for identifying HZ in routine healthcare data. It shows that HZ is common in Denmark, especially in patients with certain chronic conditions. Prioritized vaccination of such high-risk patients might be an option in countries considering alternatives to universal vaccination.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Sigrun A.J. Schmidt, Mogens Vestergaard, Lisbeth M. Baggesen, Lars Pedersen, Henrik C. Schønheyder, Henrik T. Sørensen,